The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2015 | Round table with Prof. John Gribben and Prof. Stephan Stilgenbauer on CLL
At the American Society of Hematology (ASH) 2015 Annual Meeting, John Gribben, MD, DSc and Stephan Stilgenbauer, MD discuss several topics related to chronic lymphocytic leukemia (CLL). The topics covered range from: ASH 2015 highlights; Bcl-2-targeted therapies; RESONATE-2 clinical trial; implications and challenges of long-term therapy; venetoclax (ABT-199); combination therapies; and other related topics.
